These projects were made possible from Cure Alzheimer's Fund support.
Project Description | Researchers | Funding |
---|---|---|
Human Brain CD33 Ligand, Receptor Protein Tyrosine Phosphatase Zeta (RPTPζ)S3L, Limits Microglial Phagocytosis and Contributes to Alzheimer’s Disease Progression |
2022, 2023 $402,500 |
These published papers resulted from Cure Alzheimer’s Fund support.
Gonzalez-Gil, A., Li, T. A., Kim, J., & Schnaar, R. L. Human sialoglycan ligands for immune inhibitory Siglecs, Molecular Aspects of Medicine, August 11, 2022, Read More